Axsome Therapeutics, Inc. announced the FDA has approved Auvelity, an oral drug used to treat major depressive disorder in adults quicker than other drugs on the market.
, Axsome's therapy targets several neurotransmitters including glutamate and had succeeded in a late-stage trial in 2019. The long-awaited approval for the therapy comes after the agency found deficiencies in the company's application last year and extended its review of the drug.The World Health Organization says the global prevalence of anxiety and depression increased by 25% in the first year of the COVID-19 pandemic.
Loneliness, fear of infection, suffering and death for oneself and loved ones, grief following bereavement, and financial worries were all cited as factors leading to anxiety and depression. WHO also said depression is a common illness worldwide, with an estimated 3.8% of the population affected, including 5.0% among adults and 5.7% among adults older than 60 years. Approximately 280 million people in the world have depression.Symptoms of depression include depressed mood or a loss of pleasure or interest in activities, for most of the day, nearly every day, for at least two weeks, according to WHO.
If you or a loved one is feeling distressed, call the National Suicide Prevention Lifeline. The crisis center provides free and confidential emotional support 24 hours a day, 7 days a week to civilians and veterans. Call the National Suicide Prevention Lifeline at
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Over-the-counter hearing aids may be available in the U.S. as soon as OctoberOver-the-counter hearing aids got FDA approval. Millions of Americans will have access to more affordable hearing aids by mid-October when the rule takes effect.
Read more »
Drug pipeline 2Q22 — a downturn in approvals - Nature BiotechnologyAmong the notable approvals in our 2Q22 drug pipeline Data Page are Alnylam's Amvuttra for hATTR amyloidosis, bmsnews's Camzyos, a first-in-class therapy for hypertrophic cardiomyopathy, and LillyPad's Olumiant, the first systemic drug for hair loss
Read more »
Finland's prime minister takes drug test following leaked party video“In recent days, there have been quite grave public accusations that I was in a space where drugs were used, or that I myself used drugs,” Sanna Marin told reporters.
Read more »
Abortion pill maker drops Mississippi lawsuit with national implications, but fight isn't overAbortion pill manufacturer GenBioPro voluntarily dismissed its lawsuit challenging Mississippi’s restrictions on medication abortion on Thursday, but the legal question it raised is unlikely to disappear.
Read more »
People Are Revealing Things That They've Begun To Like Less After Getting Older, And Yep, I'm Old“Getting older to reach adulthood was fun. Getting older to reach being a senior citizen is less fun.”
Read more »
Florida officials seize $12.8 million worth of drugs, arrest 85 in a two-year undercover investigationEighty-five suspects were arrested and over $12.8 million in drugs were confiscated in a two-year undercover drug trafficking investigation, the Polk County Sheriff's Office said on Friday.
Read more »